Limited brain metabolism changes differentiate between the progression and clearance of rabies virus

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Schutsky, Keith ^a   Portocarrero, Carla ^a   Hooper, D Craig ^a   Dietzschold, Bernhard ^a   Faber, Milosz ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARNITINE; CORTICOSTERONE; METYRAPONE; RABIES VACCINE; STRESS HORMONE; VIRUS RNA; 3 HYDROXYBUTYRIC ACID; ANTIVIRUS AGENT; PYRIDINE DERIVATIVE; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; ENERGY METABOLISM; FEMALE; HORMONE INHIBITION; HORMONE SYNTHESIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NONHUMAN; POST EXPOSURE PROPHYLAXIS; RABIES; RABIES VIRUS; VIRAL CLEARANCE; VIRUS INHIBITION; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE; WEIGHT REDUCTION; ADAPTIVE IMMUNITY; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BRAIN; GENE EXPRESSION; GENETICS; HOST PATHOGEN INTERACTION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; METABOLISM; VIROLOGY;

3-HYDROXYBUTYRIC ACID; ADAPTIVE IMMUNITY; ANIMALS; ANTIVIRAL AGENTS; BRAIN; CARNITINE; CORTICOSTERONE; DISEASE PROGRESSION; ENERGY METABOLISM; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; PITUITARY-ADRENAL SYSTEM; PYRIDINES; RABIES; RABIES VIRUS; VIRAL LOAD; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84899706616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087180     Document Type: Article

References (56)

1. Knobel DL, Cleaveland S, Coleman PG, Fevre EM, Meltzer MI, et al. (2005) Re-evaluating the burden of rabies in Africa and Asia. Bull World Health Organ 83: 360-368. (Pubitemid 40704865)
2. Hampson K, Dushoff J, Cleaveland S, Haydon DT, Kaare M, et al. (2009) Transmission dynamics and prospects for the elimination of canine rabies. PLoS Biol 7: e53.
3. WHO (2004) WHO technical report series 931. Geneva, Switzerland.
4. Faber M, Dietzschold B, Li J (2009) Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife. Zoonoses Public Health 56: 262-269.
5. Klingen Y, Conzelmann KK, Finke S (2008) Double-labeled rabies virus: live tracking of enveloped virus transport. J Virol 82: 237-245. (Pubitemid 350309140)
6. Tsiang H (1979) Evidence for an intraaxonal transport of fixed and street rabies virus. J Neuropathol Exp Neurol 38: 286-299.
7. Dietzschold B, Li J, Faber M, Schnell M (2008) Concepts in the pathogenesis of rabies. Future Virol 3: 481-490.
8. Wilde H (2007) Failures of post-exposure rabies prophylaxis. Vaccine 25: 7605-7609.
9. Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, et al. (2009) Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus. Proc Natl Acad Sci U S A 106: 11300-11305.
10. Li J, Ertel A, Portocarrero C, Barkhouse DA, Dietzschold B, et al. (2012) Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the Central Nervous System (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues. J Virol 86: 3200-3210.
11. Schutsky K, Curtis D, Bongiorno EK, Barkhouse DA, Kean RB, et al. (2013) Intramuscular Inoculation of Mice with the Live-Attenuated Recombinant Rabies Virus TriGAS Results in a Transient Infection of the Draining Lymph Nodes and a Robust, Long-Lasting Protective Immune Response against Rabies. J Virol 87: 1834-1841.
12. Yan X, Prosniak M, Curtis MT, Weiss ML, Faber M, et al. (2001) Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice. J Neurovirol 7: 518-527. (Pubitemid 34041053)
13. Murphy FA (1977) Rabies pathogenesis. Arch Virol 54: 279-297.
14. Jackson AC, Rossiter JP (1997) Apoptosis plays an important role in experimental rabies virus infection. J Virol 71: 5603-5607. (Pubitemid 27258239)
15. Fu ZF, Weihe E, Zheng YM, Schafer MK, Sheng H, et al. (1993) Differential effects of rabies and borna disease viruses on immediate-early- and late-response gene expression in brain tissues. J Virol 67: 6674-6681. (Pubitemid 23309135)
16. Roy A, Hooper DC (2008) Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. J Neurovirol 14: 401-411. (Pubitemid 352762879)
17. Roy A, Phares TW, Koprowski H, Hooper DC (2007) Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 81: 1110-1118. (Pubitemid 46167833)
18. Shah SH, Kraus WE, Newgard CB (2012) Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126: 1110-1120.
19. Xu XH, Huang Y, Wang G, Chen SD (2012) Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease. Neurosci Bull 28: 641-648.
20. Lafon M (2005) Rabies virus receptors. J Neurovirol 11: 82-87.
21. Lentz TL, Burrage TG, Smith AL, Tignor GH (1983) The acetylcholine receptor as a cellular receptor for rabies virus. Yale J Biol Med 56: 315-322. (Pubitemid 14160314)
22. Osio M, Muscia F, Zampini L, Nascimbene C, Mailland E, et al. (2006) Acetyl-l-carnitine in the treatment of painful antiretroviral toxic neuropathy in human immunodeficiency virus patients: an open label study. J Peripher Nerv Syst 11: 72-76. (Pubitemid 43344978)
23. Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, et al. (2008) Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 53: 3018-3025.
24. Silverman MN, Sternberg EM (2012) Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 1261: 55-63.
25. Enright JB, Goggin JE, Frye FL, Franti CE, Behymer DE (1970) Effects of corticosteroids on rabies virus infections in various animal species. J Am Vet Med Assoc 156: 765-769.
26. Roy A, Hooper DC (2007) Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 81: 7993-7998. (Pubitemid 47101484)
27. Wikoff WR, Pendyala G, Siuzdak G, Fox HS (2008) Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques. J Clin Invest 118: 2661-2669. (Pubitemid 351949793)
28. Kawashima H, Oguchi M, Ioi H, Amaha M, Yamanaka G, et al. (2006) Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci 116: 927-936. (Pubitemid 44154979)
29. Reinke SN, Resch L, Maingat F, Branton W, Jackson AC, et al. (2013) Metagenomic and metabolomic characterization of rabies encephalitis: new insights into the treatment of an ancient disease. J Infect Dis 207: 1451-1456.
30. O'Sullivan A, Willoughby RE, Mishchuk D, Alcarraz B, Cabezas-Sanchez C, et al. (2013) Metabolomics of cerebrospinal fluid from humans treated for rabies. J Proteome Res 12: 481-490.
31. Fu ZF, Li X, Dhingra V (2008) Pathogenic rabies virus alters host protein expression in the central nervous system: implications for neuronal dysfunction. Dev Biol (Basel) 131: 83-91.
32. Dhingra V, Li X, Liu Y, Fu ZF (2007) Proteomic profiling reveals that rabies virus infection results in differential expression of host proteins involved in ion homeostasis and synaptic physiology in the central nervous system. J Neurovirol 13: 107-117. (Pubitemid 46780086)
33. Scott CA, Rossiter JP, Andrew RD, Jackson AC (2008) Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. J Virol 82: 513-521. (Pubitemid 350309165)
34. Kawamata J, Shimohama S (2011) Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 24 Suppl 2: 95-109.
35. Chopy DM, Lafon M (2012) USE OF MECAMYLAMINE IN THE TREATMENT OF PATHOGEN-INFECTED PATIENTS WITH CENTRAL NERVOUS SYSTEM DISORDER. Patent Application No: PCT/EP2012/061536, Publication Date: 20.12.2012; www.wipo.int
36. Beliakov NA, Medvedev SV, Trofimova TN, Rassokhin VV, Dement'eva NE, et al. (2012) [Mechanisms of cerebral damage in patients with HIV-infection]. Vestn Ross Akad Med Nauk: 4-12.
37. Olah J, Klivenyi P, Gardian G, Vecsei L, Orosz F, et al. (2008) Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice. FEBS J 275: 4740-4755.
38. de la Monte SM (2012) Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease. Drugs 72: 49-66.
39. Jackson AC (2011) Rabies in the critical care unit: diagnostic and therapeutic approaches. Can J Neurol Sci 38: 689-695.
40. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR (1994) Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A 91: 271-275. (Pubitemid 24018686)
41. Tait AS, Butts CL, Sternberg EM (2008) The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J Leukoc Biol 84: 924-931.
42. Smets LA, Salomons G, van den Berg J (1999) Glucocorticoid induced apoptosis in leukemia. Adv Exp Med Biol 457: 607-614. (Pubitemid 129735358)
43. Jamieson AM, Yu S, Annicelli CH, Medzhitov R (2010) Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 7: 103-114.
44. Silverman MN, Pearce BD, Biron CA, Miller AH (2005) Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 18: 41-78. (Pubitemid 40586446)
45. Hemachudha T (1994) Human rabies: clinical aspects, pathogenesis, and potential therapy. Curr Top Microbiol Immunol 187: 121-143.
46. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B (1998) Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72: 3711-3719 (Pubitemid 28188669)
47. Li J, Faber M, Dietzschold B, Hooper DC (2011) The role of toll-like receptors in the induction of immune responses during rabies virus infection. Adv Virus Res 79: 115-126.
48. Jirillo E, Altamura M, Marcuccio C, Tortorella C, De Simone C, et al. (1993) Immunological responses in patients with tuberculosis and in vivo effects of acetyl-L-carnitine oral administration. Mediators Inflamm 2: S17-20. (Pubitemid 23324378)
49. De Simone C, Ferrari M, Lozzi A, Meli D, Ricca D, et al. (1982) Vitamins and immunity: II. Influence of L-carnitine on the immune system. Acta Vitaminol Enzymol 4: 135-140. (Pubitemid 12063147)
50. Janiri L, Falcone M, Persico A, Tempesta E (1991) Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo. J Neural Transm Gen Sect 86: 135-146.
51. Marcovina SM, Sirtori C, Peracino A, Gheorghiade M, Borum P, et al. (2013) Translating the basic knowledge of mitochondrial functions to metabolic therapy: role of L-carnitine. Transl Res 161: 73-84.
52. Jones LL, McDonald DA, Borum PR (2010) Acylcarnitines: role in brain. Prog Lipid Res 49: 61-75.
53. Sato M, Maeda N, Yoshida H, Urade M, Saito S (1977) Plaque formation of herpes virus hominis type 2 and rubella virus in variants isolated from the colonies of BHK21/WI-2 cells formed in soft agar. Arch Virol 53: 269-273. (Pubitemid 8065210)
54. Faber M, Faber ML, Papaneri A, Bette M, Weihe E, et al. (2005) A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol 79: 14141-14148. (Pubitemid 41552712)
55. Faber M, Faber ML, Li J, Preuss MA, Schnell MJ, et al. (2007) Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus. J Virol 81: 7041-7047. (Pubitemid 46986640)
56. Phares TW, Kean RB, Mikheeva T, Hooper DC (2006) Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 176: 7666-7675. (Pubitemid 43849067)